FDA inspection
WuXi AppTec, Inc: FDA inspection ending Mar 4, 2004
FDA inspection 315828 · No Action Indicated (NAI) · Saint Paul, MN
Key facts
| Inspection ID | 315828 |
|---|---|
| Firm | WuXi AppTec, Inc |
| FEI number | 3002199759 |
| Address | 2540 Executive Dr |
| City | Saint Paul |
| State | MN |
| ZIP | 55120-1175 |
| Fiscal year | 2004 |
| Inspection end date | Mar 4, 2004 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood & Blood Products|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies|Blood and Blood Products|Drug Quality Assurance|Human Cellular, Tissue and Gene Therapies|Human Cellular, Tissue, and Gene Therapies |
| Product type | Biologics, Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data